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Abstract
Context. Persistent pain after treatment for breast cancer (PPBCT) is
a common side effect of breast cancer treatment, with prevalence as high as 50%.
It is predominantly a neuropathic condition.
Objectives. The aim of this cross-sectional, questionnaire-based study was to
examine the emotional characteristics of patients with PPBCT in long-term breast
cancer patients. A secondary objective was to characterize the risk factors and
severity of that pain.
Methods. From March 1, 2010 to April 9, 2010, long-term follow-up patients
were invited to complete a questionnaire. This recorded their surgical and
demographic data and ascertained whether they had PPBCT. If the patient had
pain, they completed a range of validated self-report questionnaires and questions
about the nature of their pain, including a visual analogue scale.
Results. One hundred eleven patients completed the questionnaire; 33 (29.7%)
patients reported chronic pain at a median time of 64 months postoperatively
(interquartile range 54.25). Patients with persistent pain were not significantly
more anxious (t105¼"0.369, P¼ 0.713) or depressed (t105¼ 0.713, P¼ 0.507)
than patients without pain. Patients with constant pain compared with
intermittent pain were significantly more anxious (t25¼"3.460, P¼ 0.002).
Preoperative pain conferred a fivefold increased risk of PPBCT (odds ratio
[OR]¼ 5.17, 95% confidence interval [CI]¼ 1.79e14.97, P¼ 0.002);
chemotherapy conferred a threefold increased risk (OR¼ 3.004, 95%
CI¼ 1.22e7.40, P¼ 0.017).
Conclusion. We have shown significant numbers of patients suffer from PPBCT.
At a median time of 64.5 months, women with pain are not significantly more
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anxious or depressed than women without pain. Preoperative pain and
chemotherapy have been highlighted as risk factors. J Pain Symptom Manage
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rights reserved.
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Introduction
Chronic pain may be defined as pain lasting
two months or longer after the initial injury.1
Plastic changes in the nervous system contrib-
ute to the development of persistent pain.
Neuropathic pain is ‘‘pain arising as a direct
consequence of a lesion or disease affecting
the somatosensory system.’’2
Persistent pain after breast cancer treatment
(PPBCT) is a recognized problem after breast
cancer surgery. This typically neuropathic
condition3 can be subdivided into several dif-
ferent conditions with largely unknown pathol-
ogies. These include tumor-related nociceptive
pain, tumor-related neuropathic pain, and
treatment-related pain. More specifically, it
can be divided into intercostobrachial neural-
gia, phantom breast pain, neuroma pain, and
‘‘other’’ pain.4 It remains controversial whether
chemotherapy is a cause of PPBCT. Previous
studies have not demonstrated a link between
PPBCT and chemotherapy,5e7 but there is
a well-described link between chemotherapy
and peripheral neuropathic pain,8e12 and po-
tential mechanisms have been suggested.13
Reports from the U.K. and Denmark consis-
tently estimate the prevalence of PPBCT at
w50%.5,14,15 This is concerning as 50% of the
women who had pain in the Danish study had
moderate-to-severe pain.5 Further research has
examined the effects of PPBCTon women after
breast cancer surgery. One study showed that
women who reported continued pain between
seven and 12 years after surgery have a lower
quality of life.15 However, recent work from
Denmark suggests that although younger long-
termbreast cancer survivors (BCSs) report worse
health-related quality of life (HRQOL) than
the age-matched general population, older
BCS report better HRQOL than their age-
matched equivalents.16 This study also showed
that being single, having less education, and
high body mass index were risk factors for lower
HRQOL after breast cancer treatment.16
Many risk factors have been suggested, with
many possible confounding factors. Despite
this, the current literature strongly associates
younger age,3,5,6,15,17 preoperative pain, and
severe postoperative pain with increased risk
of PPBCT.6,14,17e19 Higher levels of preopera-
tive anxiety3,17e20 and the type of breast
surgery5,6,19e21 also are associated with in-
creased risk of PPBCT.
The aim of this cross-sectional, question-
naire-based study was to determine the emo-
tional and painful characteristics of patients
with PPBCT. A secondary objective was to as-
sess if known risk factors for PPBCT correlate
with risk factors in patients undergoing long-
term follow-up after breast cancer treatment.
Methods
A questionnaire (see Appendix available at
jpsmjournal.com) was constructed to ascertain
the pain and emotional characteristics of
women with PPBCT. After ethics committee
approval and an initial pilot study, all patients
attending the Edinburgh Cancer Center be-
tween March 1, 2010 and April 9, 2010 after
surgery for breast cancer were invited to com-
plete the questionnaire.
The questionnaire was designed to assess the
pain and emotional characteristics of patients
with PPBCT. It included questions assessing the
broad range of potential risk factors for PPBCT.
Patients supplied their demographic, medical,
and surgical data. Our primary objective was to
investigate the nature of the pain in women
and their emotional responses to it. Patients
were screened using the question ‘‘Do you still
experience pain as a result of your treatment?’’
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If they answered ‘‘yes,’’ they completed questions
characterizing their pain and the self-report ver-
sion of the Leeds Assessment of Neuropathic
Symptoms and Signs22 (S-LANSS) to ascertain
whether their pain was neuropathic. Patients
were asked whether they had had preoperative
pain (not necessarily breast pain). Patients then
filled out the Chronic Pain Acceptance Ques-
tionnaire (CPAQ)20 to assess behavioral mea-
sures of pain, specifically ‘‘pain willingness’’ and
‘‘activities engagement.’’ At the end of the ques-
tionnaire, all patients completed the Hospital
Anxiety and Depression Scale23 (HADS). This
determined whether the patients with pain
were more anxious or depressed than patients
without pain.
Statistical and Analytical Methods
Age, time since surgery, and HADS scores
were analyzed using independent sample t-tests
between patients who reported chronic pain
and those who did not. The CPAQ and
S-LANSS were analyzed using independent
sample t-tests between patients with constant
pain and those with intermittent pain. Type of
surgery, chemotherapy, radiotherapy, hormone
therapy, and the presence of preoperative
pain were analyzed using a cross-tabulation
and c2 test. All analyses were performed using
SPSS v17.0 (SPSS, Inc., Chicago, IL). Alpha
was set at 0.05.
Logistic regression methods were used to
assess the impact of procedure, age, time since
surgery, preoperative pain, chemotherapy, radio-
therapy, and hormone therapy on postoperative
pain, as univariate variables and in combination.
Results
Before the analysis, all variables were checked
to confirm that they met assumptions for para-
metric analysis. The baseline characteristics
are shown in Table 1. One hundred eleven pa-
tients completed the questionnaire at a mean
time of 64.5 months postoperatively, of whom
33 (29.7%) reported chronic pain.
Independent sample t-tests were performed
(Table 2). No difference in time since surgery
by development of chronic pain was found
(P¼ 0.89). Younger age was not significantly
associated with the development of chronic
pain, although there was a trend toward signif-
icance (P¼ 0.07).
Characterizing PPBCT
If a patient reported PPBCT, they also an-
swered questions characterizing their pain in
terms of location, time of onset, duration, and
exacerbating factors. Patients were allowed to
tick multiple responses for each question. Pain
immediately after surgery was reported by
35.7% of patients, 32.1% reported pain starting
months postoperatively, and 7.1% reported
pain beginning years postoperatively; 17.9% of
patients who reported chronic pain said that
they had pain before their operation.
Patients were asked whether their pain was
intermittent. Of the 30 respondents, seven
(23.3%) said pain was constant and 23 (76.7%)
said the pain came and went. The questions
went on to characterize the duration of the
pain. Of the 25 respondents, 29.2% said that
their pain lasted for seconds, 16.7% said it lasted
forminutes, 20.8% said it lasted forhours, 12.5%
said it lasted for weeks, and 20.8% described the
duration of their pain as variable.
Exercise exacerbated pain in 32.1% of pa-
tients. Exacerbations also were reported in rela-
tion to dressing (21.4%), lifting (7.1%), writing
(3.6%), using the phone (3.6%), and other fac-
tors (21.4%); 42.9% of patients reported that
nothing exacerbated their pain.
Twenty-two of 33 (66.6%) patients reporting
chronic pain were taking analgesic medications,
of which the most popular were paracetamol
(acetaminophen), ibuprofen, and cocodamol.
Thirteen patients gave details of analgesic effi-
cacy, and, only two said that analgesics relieved
their pain. The rest either answered ‘‘no’’
(one), ‘‘sometimes’’ (seven), and ‘‘not sure’’
Table 1
Baseline Characteristics of Women Treated for
Breast Cancer From 1997 to 2009
Baseline Characteristics (N¼ 111) Mean (SD)
Age (years) 64.43 (10.95)
Number of operations 1.23 (0.56)
Time since surgery in months, n¼ 110 64.51 (39.42)
Baseline Characteristics (N¼ 111) N (%)
Patients who had chemotherapy, n¼ 100 43 (43.0)
Patients who had radiotherapy 92 (82.9)
Hormone therapy, n¼ 110 77 (70.0)
Chronic pain as a result of treatment 33 (29.7)
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(three). Slightly surprisingly, only six patients
wanted to see a physician about their pain.
Twenty-five of 33 (76%)patients who reported
chronic pain completed the S-LANSS. Ten
(40%) patients scored 12þ, indicating that their
pain was likely to be neuropathic; another four
respondents scored 11 and were, therefore, bor-
derline. Of the original 111 patients,w30% had
chronic pain and 40% of these patients had neu-
ropathic pain. However, the S-LANSS is only
a screening tool and cannot replace specialist
clinical judgment. It has been shown to be a con-
servative measure of neuropathic pain,22 and,
therefore, we can conservatively estimate the
prevalence of chronic neuropathic pain in this
population at 9% but it is likely to be higher.
The mean visual analogue scale (VAS) score
was used to determine the patient’s average
pain over the last week. Twenty-three patients re-
sponded, and the mean score was 3.23$ 2.61
and, therefore, the mean pain was mild to mod-
erate (VAS< 4). However, five (21.7%) patients
were in the moderate range (VAS> 4) and two
(8.6%) were in the severe range (VAS> 8).
This suggests a very broad spectrum of pain
severity.
Emotional/Affective Factors
The HADS scores were analyzed as
HADS-Anxiety and HADS-Depression Scores
(Table 2). Patients with PPBCTwere not signif-
icantly more anxious or depressed compared
with patients who did not have pain. However,
a subset analysis of patients with pain showed
that patients who described their pain as
constant had significantly greater anxiety
(P¼ 0.002) compared with patients who re-
ported intermittent pain.
The CPAQ is designed to assess patients’ ‘‘ac-
tivities engagement’’ and ‘‘pain willingness;’’
higher scores indicate greater amounts of
pain acceptance and activities engagement.
The mean engagement score was 51.27 (of
a maximum 66) and the mean pain willingness
score was 39.73 (of a possible 54). The CPAQ
scores were analyzed by an independent sam-
ple t-test between those who reported that
their pain was constant and those with inter-
mittent pain. Participants with constant pain
had significantly lower pain willingness scores
(P¼ 0.037), indicating greater difficulties
with pain acceptance, compared with those
with intermittent pain.20
Medical and Surgical Risk Factors
No surgical procedure was significantly asso-
ciated with increased risk of developing PPBCT.
Preoperative pain, chemotherapy, and radio-
therapy all showed varying degrees of associa-
tion with the development of chronic pain
(Table 3). These variables were then analyzed
within amore comprehensivemodel anda logis-
tical regression analysis was performed.
The logistic regression analysis only allows
chemotherapy and preoperative pain into
the model. Chemotherapy was shown to in-
crease risk of developing chronic pain by
a factor of 3.00 (95% confidence interval
[CI]¼ 1.22e7.40, P¼ 0.017). Preoperative
pain was shown to confer a fivefold increased
risk (95% CI¼ 1.78e14.9, P¼ 0.002) of devel-
oping chronic pain.
Discussion
As a group, the patients with PPBCT did
not display significantly greater anxiety or de-
pression scores when compared with patients
who did not have pain. This may partly explain
Table 2
Comparison of Age, Time Since Surgery, and HADS Scores Between Patients Treated for Breast Cancer From
1997 to 2009 With and Without Chronic Paina
Parameters
No Chronic Pain (N¼ 78) Chronic Pain (N¼ 33)
Mean Difference (95% CI)
t-test
Mean (SD) Mean (SD) P-value
Age (years) 65.68 (10.73) 61.48 (11.08) 4.20 ("0.27, 8.65) 0.065
Time since surgery in months 64.86 (37.36) 63.66 (44.68), n¼ 32 1.20 ("15.28, 17.68) 0.89
HADS-A 4.87 (4.20) 5.21 (4.14), n¼ 29 "0.34 ("2.14, 1.47) 0.71
HADS-D 2.86 (2.88) 2.45 (2.71), n¼ 29 0.41 ("0.81, 1.63) 0.51
S-LANSS (n¼ 25) ee 8.36 (6.10) ee ee
HADS-A¼Hospital Anxiety and Depression Scale-Anxiety; HADS-D¼Hospital Anxiety and Depression Scale-Depression; S-LANSS¼ Self-Report
Leeds Assessment of Neuropathic Symptoms and Signs.
at-test.
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why only a small number of patients wanted to
consult a physician and is supported by recent
research.16
The severity of pain was at the top of the mild
range. This is somewhat reassuring because pre-
vious studies have reported higher pain scores
and also may partly explain why few women
wanted to consult a physician.5 Patients with
constant pain had significantly greater anxiety
scores than patients whose pain was intermit-
tent. This group also had lower ‘‘pain willing-
ness’’ scores as measured by the CPAQ. This
indicates that there is a subgroup of patients
(w6% of the total) who have constant pain
and anxiety. This may be the result of the sever-
ity of their pain, the neuropathic element,
which makes it more difficult to treat, or the
fact that it is constant. Further prospective stud-
ies with larger numbers may clarify the recipro-
cal relationships among pain, treatment, and
distress.
The estimates for the prevalence of PPBCTare
consistentlyw50% for women at a mean time of
between 24 and 36months postoperatively.5,14,15
We have shown in our sample that the percent-
age of women experiencing chronic pain after
surgery for breast cancer was 29.7%, significantly
lower than previous estimates. This study has
a mean time since surgery of 64.5 months and
so takes a longer-term view than previous stud-
ies.5 However, there is a large variation in
follow-up time, which makes interpretation of
the prevalence of PPBCTat a specific time point
difficult.Ourpatientswere treatedbetween1997
and 2009, and we should remember that treat-
ment for breast cancer has changed a lot in this
period; thismaymake this sample group less rep-
resentative than modern BCSs.
Similar to other research, the present study
didnot finda correlationbetween time since sur-
gery and the risk of development of PPBCT.14 A
previous study suggests that at a mean follow-up
time of nine years, there is a chronic pain rate
of 17%, down from a rate of 43% at three years
postoperatively.15 The present study loosely sup-
ports suggestions from previous research that
chronic pain following treatment for breast can-
cer resolveswith time for aproportionofwomen.
However, the large range in follow-up timeneeds
to be borne in mind. It seems that the relation-
ship between length of time since surgery and
the development of chronic pain is complex
and influenced by several factors. The present
study also supports the finding that, for a propor-
tion of women, PPBCT does not resolve even
after a considerable length of time.
PPBCT is very variable and it can manifest it-
self at various times in the course of a patient’s
treatment. Approximately 40% of the pain is
likely to be neuropathic and thus likely to be
less responsive to standard analgesics. A sub-
stantial number of patients may benefit from
access to specialist advice and consultation
around the use of antineuropathic agents.
Chemotherapy was shown to significantly in-
crease the risk of developing chronic pain.
This finding is supported by the large body of
previous literature showing that chemotherapy
Table 3
Comparison of Preoperative Pain, Type of Operation, Radiotherapy, and Chemotherapy Between Patients
Treated for Breast Cancer From 1997 to 2009 With and Without Chronic Paina
Parameters
No Chronic Pain (N¼ 78) Chronic Pain (N¼ 33)
Mean Difference in %
(95% CI), Pain-No Pain
c2/Fisher’s Exact Test
N (%) N (%) P-value
Preoperative pain 8 (10.3) 12 (36.4) 26.11 (8.37, 43.85) 0.001b
Operation d d d d
Lumpectomy 64 (82.1) 30 (90.9) 8.86 ("4.13, 21.85) 0.24
Re-excision 2 (2.6) 4 (12.1) 9.56 ("2.12, 21.23) 0.06
Mastectomy 14 (17.9) 6 (18.2) 0.23 ("15.44, 15.91) 0.98
SNB 13 (16.7) 5/32 (15.6) "1.04 ("16.10, 14.01) 0.89
ANC 27 (34.6) 11 (33.3) "1.28 ("20.52, 17.96) 0.90
ANS 27 (34.6) 14 (42.4) 7.81 ("12.09, 27.70) 0.43
Reconstruction 5 (6.4) 4 (12.1) 5.71 ("6.68, 18.10) 0.31
Implant 1 (1.3) 1 (3.0) 1.74 ("4.61, 8.11) 0.53
Radiotherapy 61 (78.2) 31 (93.9) 15.73 (3.48, 27.99) 0.04b
Chemotherapy 24/68 (35.3) 19/32 (59.4) 24.08 (3.62, 44.54) 0.023b
SNB¼ sentinel node biopsy; ANC¼ axillary node clearance; ANS¼ axillary node sample.
ac2/Fisher’s exact test.
bDenotes significant results.
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is a risk factor for peripheral neuropathic
pain.8e12 These findings, however, are equi-
vocal as there is a body of literature that finds
no association between chemotherapy and
PPBCT.5e7 Also, it cannot be ruled out that it
is because younger women (who are at greater
risk of PPBCT) were more likely to receive che-
motherapy. Clearly, further prospective longitu-
dinal research is required. This area also may
benefit from systematic review.
Although the exact mechanisms underlying
the link between chronic pain and chemother-
apy have not been clarified, it is thought that
axoplasmic disruption of microtubule trans-
port, distal axonal degeneration, and damage
to cell bodies in the dorsal root ganglion may
be responsible.13 The peripheral nervous sys-
tem may be particularly susceptible because of
the lack of an effective neurovascular barrier.13
Our study did not demonstrate an association
between younger age and increased risk of
chronic pain, but there was a trend toward sig-
nificance. We also did not show an association
between different types of operation and in-
creased risk of developing chronic pain; this is
similar to some smaller studies24 but contradicts
many others.5,6,9,21
Although thequestionnaire reliedonaccurate
information from patients (demographic, surgi-
cal, and medical data), the items within the
questionnaire have all been validated for self-
reporting by patients.20,22,23,25 Epidemiological
studies have demonstrated that patients can
accurately report such data especially when it
involves life-threatening conditions.26 Also, as
a cross-sectional questionnaire study, it is liable
to self-selection bias as people can choose
whether theywish to complete the questionnaire
or not. Finally, our results in relation to preoper-
ative pain do rely on patients retrospectively re-
membering whether they had pain before their
operation. Although we believe patients can ac-
curately recall this, itmeans that this result needs
to be interpreted with caution.
In conclusion, this study shows that, as awhole,
long-term BCSs are not significantly more
anxious or depressed than long-term survivors
without pain. Importantly, however, this study
suggests that patients with constant pain are sig-
nificantly more anxious than patients with inter-
mittent pain. This could mean that there is
a subgroup of patients, approximately 6% of
the total, with constant PPBCT and anxiety.
Patients with constant pain had significantly
lower pain willingness scores on the CPAQ.
This suggests areas of future research around
longitudinal studies of psychological factors in
breast cancer treatment andhow these influence
pathways toward health and recovery. Our study
may have been somewhat underpowered to as-
sess risk factors, but these seem to include preop-
erative pain and chemotherapy. The persistence
of PPBCT in BCSs and its prevalence suggests
that long-term follow-up patients should be reg-
ularly asked about any painful symptoms. More
patients could thenbereferred topain specialists
for treatment.
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